Including hot topics like iPS/ES Cell, Antibody Drug, Companion Diagnostics etc., everything on the Asian life science industry will be revealed here.
*FREE with Member Registration (except Keynote Session)
BIO-K
Keynote Session |
May 8 [Wed] 10:30-12:30Bilingual (English/Japanese)
Frontline of Stem Cell Research and Strategies for Success in the Pharmaceutical Industry |
 Session Chair:Ken-ichi Arai
Professor Emeritus, The University of Tokyo /
President and CEO, SBI Biotech Co., Ltd. |
Normal and Neoplastic Stem Cells |
Irving Weissman
Professor, Pathology, Developmental Biology Director,
Institute for Stem Cell Biology & Regenerative Medicine,
Stanford University |
The Global Outlook for Life Sciences: Trends and Opportunities in the New Healthcare Eco System |
|
Reenita Das
Senior Vice President, Global Healthcare & Life Sciences,
Frost & Sullivan |
|
Challenges to Rare Diseases ―Diseases Physicians are Unaware of― |
Yoshikazu Nakamura
President, Genzyme Japan
Regional President, Genzyme Japan-Asia Pacific
|
(Note: This Session will proceed with 3 speakers. Please note that the above is the latest information and it differs from the information on the VIP INVITATION and Invitation Tickets.)
FREE with Member Registration
Special Session-1 |
Bilingual (English/Japanese)May 8 [Wed] 13:30-15:00
Roadmap to Drug Discovery Targeting Cancer Stem Cells |
 Session Chair:Tatsumi Yamazaki
Deputy President, Member of the Board,
Chugai Pharmaceutical Co., Ltd. |
The Leukemic Stem Cell: An Ultimate Therapeutic Target for Cure |
|
Koichi Akashi
Professor and Director,
Dept. of Medicine and Biosystemic Science, Faculty of Medicine,
Kyushu University |
Establishment of Human Colon Cancer Stem Cell Lines and Drug Discovery against Cancer Stem Cells |
|
Hisafumi Okabe
Vice President, General Manager,
Research Div.
Chugai Pharmaceutical Co., Ltd. |
FREE with Member Registration
Special Session-2 |
Bilingual (English/Japanese)May 8 [Wed] 16:00～17:30
Keys to Success in Antibody Drug Development: Technologies to Extract Difficult Antibodies |
Session Chair:Yuzuru Matsuda
Senior Advisor, Kyowa Hakko Kirin Co., Ltd. |
The Latest Trend and Challenges in the Development of Future Therapeutic Antibodies |
Masa Fujiwara
President & CEO,
Chiome Bioscience Inc. |
Possibilities of Successful Translational Research towards Clinical Trials by Japanese Academia |
Ryuzo Ueda
Professor, Dept. of Tumor Immunology,
Aichi Medical University School of Medicine |
FREE with Member Registration
Special Session-3 |
May 9 [Thur] 10:30-12:00Bilingual (English/Japanese)
iPS/ES Cell Research Frontｌine ―Entering a New Phase ― |
 Session Chair:Hideyuki Okano
Professor, Dept. of Physiology, Keio University School of Medicine
|
A Promising Strategy of Myocardial Regeneration for Severely Damaged Myocardium |
Yoshiki Sawa
Professor and Chairman,
Dept. of Cardiovascular Surgery,
Osaka University Graduate School of Medicine |
iPS Technology and its Potential for Future Medicine |
Hiro Nakauchi
Professor and Director,
Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science,
The University of Tokyo |
FREE with Member Registration
Special Session-4 |
May 9 [Thur] 10:30-12:00Bilingual (English/Japanese)
Gene Engineering and Biorefinery Technology Updates: toward Practical Use |
 Session Chair:Takuji Sasaki
Professor, NODAI Research Institute, Tokyo University of Agriculture |
The Current Situation of Plant-made Pharmaceuticals Using Plant Production Systems with Artificial Lamps Alone |
Takeshi Matsumura
Plant Molecular Technology Research Group Leader,
Bioproduction Research Institute,
National Institute of Advanced Industrial Science and Technology (AIST) |
Development of Biorefinery based on Innovative Bioproduction
|
Akihiko Kondo
Professor, Director of Biorefinery Center,
Dept. of Chemical Science and Engineering
Graduate School of Engineering, Kobe University |
FREE with Member Registration
Special Session-5 |
May 9 [Thur] 13:00-14:30Bilingual (English/Japanese)
Challenges of Regenerative Medicine: 3-D Tissue Engineering |
 Session Chair:Teruo Okano
Professor and Director, Member of the Science Council of Japan,
Tokyo Women's Medical University |
Realization of Cartilage Regeneration by Cell Sheets Accelerating Joint Treatment |
|
Masato Sato
Professor,
Dept. of Orthopaedic Surgery, Surgical Science,
Tokai University School of Medicine |
Making Hearts: Challenges of Functional 3-D Tissue & Organ Engineering |
|
Tatsuya Shimizu
Professor,
Institute of Advanced Biomedical Engineering and Science,
Tokyo Women's Medical University |
FREE with Member Registration
Special Session-6 |
May 9 [Thur] 13:00-15:00Bilingual (English/Japanese)
Structure-based Drug Design: By Super Computer "Kei" and Conformations |
 Session Chair:Tatsuhiko Kodama
Professor, Dept. of Systems Biology and Medicine,
Research Center for Advanced Science and Technology, The University of Tokyo |
Structure-based Drug Design on Membrane Protein Targets |
So Iwata
Professor,
Dept. of Cell Biology, Graduate School of Medicine,
Kyoto University |
X-ray Structural Analysis for Molecular Design of Antibody Fragments and the Development of Novel Crystallization Method |
Tsuyoshi Inoue
Professor, Dept. of Applied Chemistry,
Osaka University |
|
Molecular Dynamics Simulations of Protein Solution Based on X-ray Crystal Structures |
Hideaki Fujitani
Professor,
Research Center for Advanced Science and Technology,
The University of Tokyo
|
FREE with Member Registration
Special Session-7 |
May 10 [Fri] 10:30-12:00Bilingual (English/Japanese)
New Therapeutic Strategies based on the Analysis and Interpretation of Human Immune System |
 Session Chair:Hiroshi Kiyono
Dean and Professor, The Institute of Medical Science,
The University of Tokyo |
Application of Humanized Mouse System into the Creation of Therapeutic Strategies against Human Diseases |
|
Fumihiko Ishikawa
Group Director, Lab. for Human Disease Model,
RIKEN IMS |
Emerging Roles for Basophils in Allergy and Protective Immunity: A Neglected Minority Gains New Respect
|
|
Hajime Karasuyama
Professor, Dept. of Immune Regulation, Graduate School,
Tokyo Medical and Dental University |
FREE with Member Registration
Special Session-8 |
May 10 [Fri] 10:00-12:00Bilingual (English/Japanese)
Personalized Medicine ―Future Perspective and Endorsement ― |
 Session Chair:Shuichi Hayashi
Vice President and Head of In Vitro Diagnostics,
Roche Diagnostics K.K. |
| Facilitator: Tsutomu Nobori, Professor, Depｔ. of Molecular and Laboratory, Mie University Graduate School of Medicine |
Exploring Personalized Healthcare (PHC) Innovative Approaches in Neuroscience Drug Discovery |
Emilio Merlo Pich
Head, Clinical Imaging, Neuroscience DTA pRED,
F. Hoffmann-La Roche Ltd. |
Development and Perspective of Molecular Diagnosis for Multiple Alterations |
Yasushi Yatabe
Chief, Dept. of Pathology & Molecular Diagnostics,
Aichi Cancer Center Hopsital
|
|
Medical Care Innovation in Japan ―Accelerating Regulatory Science Initiative for Personalized Medicine― |
Toshio Miyata
Deputy Director,
Evaluation and Licensing Div., Pharmaceutical and Food Safety Bureau,
Ministry of Health, Labour and Welfare
|
FREE with Member Registration
Special Session-9 |
May 10 [Fri] 13:00-14:30Bilingual (English/Japanese)
Frontier of Medicine-engineering Collaboration ―Engineering Approaches to Further Medical Development― |
 Session Chair:Kazunori Kataoka
Professor, Dept.of Materials Engineering, Graduate School of Engineering, and Center for Disease Biology
and Integrative Medicine, Graduate School of Medicine, The University of Tokyo |
Engineering Study for Minimally Invasive Therapy |
Ichiro Sakuma
Professor/Director,
Medical Device Development and Regulation Research Center,
The University of Tokyo |
Frontier of Medicine-engineering Synergetic Cooperation in Regenerative Medicine
―Materials and Manufacturing Technologies for Regeneration Therapy and Researches― |
Yasuhiko Tabata
Professor, Institute for Frontier Medical Sciences,
Kyoto University |
FREE with Member Registration
Special Session-10 |
May 10 [Fri] 13:00-15:00Bilingual (English/Japanese)
"All Japan" Integrated Promotion and Collaboration toward Drug Discovery Innovation |
 Session Chair:Toichi Takenaka
Chairman of the Board, Japan Health Sciences Foundation |
RIKEN Drug Discovery
―Life Innovation from Japanese Academia― |
|
Toshio Goto
Director,
Program for Drug Discovery and Medical Technology Platforms,
RIKEN |
| R&D for Innovative Pharmaceuticals in AIST |
|
Noboru Yumoto
Vice President, Director-General for Life Science and Biotechnology,
National Institute of Advanced Industrial Science and Technology (AIST) |
|
Research and Development for Innovative Pharmaceuticals in NIBIO |
Yoichi Kurebayashi
Director,
National Institute of Biomedical Innovation (NIBIO)
|
-(Honorifics omitted) Please note that the speakers and programs are subject to change.
The photographic and video recording rights are reserved to the Show Management.
About BIO tech 2013 bio-e@reedexpo.co.jp